137.84, 135.34, 131.35, 129.76, 129.12, 127.46, 126.53, 120.44,
1-Allyl-3-(4-nitrophenyl)-1-phenylurea (1d)
116.87, 52.29, 20.79 ppm; ESI HRMS m/z [M+H]+ calcd
1
Yellow crystalline solid, mp=(123–125)8C; H NMR (400 MHz, Ace-
266.1419 gmolÀ1. Observed 367.1509 gmolÀ1
.
tone) d=8.00–7.95 (m, 1H), 7.89 (s, 1H), 7.61–7.54 (m, 1H), 7.38–
7.16 (m, 2H), 5.82 (ddt, J=17.2, 10.2, 6.0 Hz, 1H), 4.98 (ddq, J=
13.2, 10.2, 1.5 Hz, 1H), 4.23 ppm (dt, J=6.0, 1.4 Hz, 1H); 13C NMR
(75 MHz, Acetone) d=153.39, 146.67, 141.86, 141.31, 134.29,
129.88, 128.17, 127.61, 124.43, 118.39, 116.62, 52.46 ppm; ESI HRMS
m/z: calcd 297.1113 gmolÀ1. Observed 298.1210 gmolÀ1
1-Allyl-3-(4-methoxyphenyl)-1-phenylurea (1j)
White crystalline solid, mp=(111–112)8C; 1H NMR (500 MHz,
[D6]DMSO) d=7.85 (s, 1H), 7.42–7.23 (m, 7H), 6.82–6.79 (m, 2H),
5.88 (ddd, J=22.6, 10.6, 5.5 Hz, 1H), 5.11 (ddd, J=13.7, 11.4, 1.3 Hz,
2H), 4.31 (d, J=5.5 Hz, 2H) 3.68 ppm (s, 3H); 13C NMR (126 MHz,
[D6]DMSO) d=154.98, 143.07, 135.41, 133.41, 129.74, 127.49,
126.47, 122.31, 116.83, 113.91, 55.59, 52.28 ppm; ESI HRMS m/z
1-Allyl-3-(perfluorophenyl)-1-phenylurea (1e)
White crystalline solid, mp=(72–73)8C; 1H NMR (300 MHz, CDCl3)
d=7.43–7.00 (m, 10H), 6.84 (t, J=6.8 Hz, 1H), 6.16 (s, 1H), 5.82
(ddt, J=16.4, 10.5, 6.1 Hz, 1H), 5.14–4.90 ppm (m, 2H), 4.21 (d, J=
6.1 Hz, 2H); 13C NMR (75 MHz, CDCl3) d=153.34, 140.80, 133.24,
130.37, 128.63, 128.38, 118.12, 77.47, 77.04, 76.62, 52.89 ppm;
19F NMR (376 MHz, DMSO) d=À146.47, À146.52, À146.53,
À160.07, À160.13, À160.19, À164.14, À164.20, À164.25,
À164.26 ppm; ESI HRMS m/z [M+H]+calcd 342.0792 gmolÀ1 Ob-
[M+H]+ calcd 282.1368 gmolÀ1. Observed 283.1452 gmolÀ1
.
1,3-Diphenyl-4-(((2,2,6,6-tetramethylpiperidin-1-yl)oxy)me-
thyl)imidazolidin-2-one (2a)
White crystalline solid, mp=(133.4–134.7)8C; 1H NMR (300 MHz,
DMSO) d=7.66–7.46 (m, 4H), 7.35–7.17 (m, 4H), 7.05–6.83 (m, 2H),
4.84–4.50 (m, 1H), 4.05 (t, J=9.4 Hz, 1H), 3.81 (dd, J=9.7, 3.4 Hz,
1H), 3.73–3.62 (m, 2H), 1.56–0.99 (m, 6H), 0.94 (s, 1H), 0.82 (s, 1H),
0.66 (s, 1H), 0.59 ppm (s, 1H). 13C NMR (75 MHz, DMSO) d=154.88,
140.63, 139.09, 129.18, 128.97, 123.80, 122.69, 121.41, 117.98, 75.55,
59.93, 59.72, 51.60, 45.47, 33.22, 32.54, 19.91, 16.87 ppm. ESI HRMS
served 343.0866 gmolÀ1
.
1-Allyl-3-(naphthalen-2-yl)-1-phenylurea (1 f)
White crystalline solid, mp=(117–118)8C; 1H NMR (400 MHz, Ace-
tone) d=7.93 (d, J=2.0 Hz, 1H), 7.62 (d, J=8.5 Hz, 1H), 7.60–7.56
(m, 2H), 7.40–7.14 (m, 9H), 5.84 (ddt, J=17.2, 10.2, 6.0 Hz, 1H),
5.07–4.86 (m, 2H), 4.24 ppm (dt, J=6.0, 1.4 Hz, 2H); 13C NMR
(101 MHz, Acetone) d=154.02, 142.01, 137.82, 134.89, 134.11,
129.84, 129.82, 128.21, 127.91, 127.40, 127.29, 127.11, 126.08,
123.99, 120.46, 116.28, 114.85, 52.17 ppm; ESI HRMS m/z: calcd
302.1419 gmolÀ1. Observed 303.1493 gmolÀ1
m/z [M+H]+ calcd 407.2573 gmolÀ1 Observed 408.2643 gmolÀ1
.
1-Phenyl-4-(((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)-
3-(4 (trifluoromethyl)phenyl)imidazolidin-2-one (2b)
Off white crystalline solid, mp=(135–138)8C; 1H NMR (300 MHz,
CDCl3) d=7.64 (d, J=8.7 Hz, 2H), 7.56–7.48 (m, 4H), 7.35–7.27 (m,
2H), 7.08–6.99 (m, 1H), 4.61–4.46 (m, 1H), 4.04 (t, J=9.2 Hz, 1H),
3.90 (d, J=5.0 Hz, 2H), 3.79 (dd, J=9.1, 4.3 Hz, 1H), 1.50–1.11 (m,
6H), 1.03 (s, 3H), 0.95 (s, 3H), 0.82 ppm (s, 6H), 13C NMR (75 MHz,
CDCl3) d=154.65, 141.84, 139.61, 130.40, 128.98, 128.49, 125.97,
125.92, 125.47, 125.04, 123.41, 122.44, 120.13, 118.48, 118.34, 75.80,
60.03, 51.37, 45.80, 39.57, 33.02, 32.82, 20.03, 19.86, 16.90 ppm,
19F NMR (376 MHz, Acetone) d=À67.21 ppm. ESI HRMS m/z
N-(Allyl(phenyl)carbamoyl)-4-methylbenzenesulfonamide
(1g)
White crystalline solid, mp=(114–115)8C; 1H NMR (400 MHz, Ace-
tone) d=8.78 (s, 1H), 7.78–7.70 (m, 2H), 7.35–7.08 (m, 7H), 5.76–
5.54 (m, 1H), 5.02–4.78 (m, 2H), 4.04 (dt, J=6.1, 1.4 Hz, 2H),
2.30 ppm (s, 3H); 13C NMR (126 MHz, Acetone) d=150.73, 143.89,
140.53, 137.78, 133.43, 129.72, 129.10, 128.28, 128.26, 127.85,
[M+H]+ calcd 475.2447 gmolÀ1 Observed 476.2525 gmolÀ1
.
117.12, 52.32, 20.65 ppm.; ESI HRMS m/z: calcd 330.1038 gmolÀ1
Observed 331.1118 gmolÀ1
.
3-(3,5-Bis(trifluoromethyl)phenyl)-1-phenyl-4-(((2,2,6,6-tetra-
methylpiperidin-1-yl)oxy)methyl)imidazolidin-2-one (2c)
White crystalline solid, mp=(151–153)8C; 1H NMR (400 MHz,
CDCl3) d=8.05 (s, 2H), 7.60–7.45 (m, 3H), 7.39–7.23 (m, 2H), 7.13–
6.97 (m, 1H), 4.69–4.49 (m, 1H), 4.09 (t, J=9.2 Hz, 1H), 4.01–3.84
(m, 2H), 3.73 (dt, J=14.9, 7.5 Hz, 1H), 1.52–1.20 (m, 6H), 1.01 (s,
3H), 0.94 (s, 3H), 0.86 (s, 3H), 0.72 ppm (s, 3H), 13C NMR (101 MHz,
Acetone) d=154.27, 141.82, 139.99, 131.57, 131.24, 128.71, 125.01,
122.99, 122.30, 120.21, 120.18, 118.07, 115.49, 115.45, 115.41, 76.90,
59.71, 59.59, 51.19, 45.37, 39.46, 39.45, 32.51, 32.16, 19.21, 19.07,
16.65 ppm, 19F NMR (376 MHz, Acetone) d=À68.15 ppm. ESI HRMS
1-(2-Allylphenyl)-3-(1-(naphthalen-1-yl)ethyl)urea (1h)
Off white liquid; 1H NMR (300 MHz, CDCl3) d=8.09 (d, J=8.4 Hz,
1H), 7.75 (d, J=7.8 Hz, 1H), 7.65 (d, J=8.1 Hz, 1H), 7.52–7.35 (m,
2H), 7.34–7.04 (m, 7H), 5.92–5.66 (m, 2H), 5.02 (dd, J=2.9, 1.5 Hz,
1H), 4.97 (dt, J=4.6, 1.4 Hz, 1H), 4.52 (d, J=7.9 Hz, 1H), 4.22 (dt,
J=6.0, 1.3 Hz, 2H), 1.46 ppm (d, J=6.8 Hz, 3H); 13C NMR (75 MHz,
CDCl3) d=155.92, 141.79, 139.63, 134.62, 133.92, 130.99, 129.89,
128.71, 128.23, 127.91, 127.50, 126.28, 125.70, 125.17, 123.65,
122.09, 116.89, 52.32, 46.28, 21.94 ppm.; ESI HRMS m/z: calcd
330.1732 gmolÀ1. Observed 331.1807 gmolÀ1
m/z [M+H]+ calcd 543.2320 gmolÀ1 Observed 544.2419 gmolÀ1
.
3-(4-Nitrophenyl)-1-phenyl-4-(((2,2,6,6-tetramethylpiperidin-
1-yl)oxy)methyl)imidazolidin-2-one (2d)
1-Allyl-1-phenyl-3-(p-tolyl)urea (1i)
White crystalline solid, mp=(113–114)8C; 1H NMR (500 MHz,
[D6]DMSO) d=7.89 (s, 1H), 7.42–7.01 (m, 9H), 5.88 (m, 1H), 5.11
(ddq, J=17.1, 10.3, 1.5 Hz, 2H), 4.31 (dt, J=5.5, 1.4 Hz, 2H),
2.22 ppm (s, 3H); 13C NMR (126 MHz, [D6]DMSO) d=154.80, 143.04,
Yellow crystalline solid, mp=(163.5–167)8C; 1H NMR (300 MHz,
Acetone) d=8.13 (d, J=9.3 Hz, 2H), 7.95 (d, J=9.3 Hz, 2H), 7.61
(d, J=7.9 Hz, 2H), 7.26 (t, J=8.0 Hz, 2H), 6.97 (t, J=7.3 Hz, 1H),
4.88 (d, J=6.3 Hz, 1H), 4.20 (t, J=9.3 Hz, 1H), 4.05 (dd, J=9.9,
ChemistryOpen 2017, 00, 0 – 0
5
ꢀ 2017 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
These are not the final page numbers! ÞÞ